$NTIC
NORTHERN TECHNOLOGIES INTERNATIONAL CORP Stock $ntic

$ntic Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000117184324000207 Filed on January 11, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$20.84M	$20.18M
YoY Change	14.08%	1.15%
Cost Of Revenue	$12.50M	$12.85M
YoY Change	5.36%	-5.53%
Gross Profit	$8.339M	$7.334M
YoY Change	30.23%	15.44%
Gross Profit Margin	40.01%	36.34%
Selling, General & Admin	$7.372M	$7.203M
YoY Change	13.36%	8.51%
% of Gross Profit	88.4%	98.21%
Research & Development	$1.242M	$1.106M
YoY Change	24.92%	-12.0%
% of Gross Profit	14.9%	15.08%
Depreciation & Amortization	$290.4K	$307.0K
YoY Change	28.51%	16.79%
% of Gross Profit	3.48%	4.19%
Operating Expenses	$8.614M	$8.309M
YoY Change	14.89%	5.25%
Operating Profit	$2.206M	$1.376M
YoY Change	71.39%	65.92%
Interest Expense	$77.76K	$111.1K
YoY Change	-32.47%	21.69%
% of Operating Profit	3.52%	8.07%
Other Income/Expense, Net
YoY Change
Pretax Income	$2.158M	$1.312M
YoY Change	83.54%	76.21%
Income Tax	$289.2K	$226.8K
% Of Pretax Income	13.4%	17.29%
Net Earnings	$1.701M	$895.5K
YoY Change	92.17%	78.3%
Net Earnings / Revenue	8.16%	4.44%
Basic Earnings Per Share	$0.18	$0.09
Diluted Earnings Per Share	$0.17	$0.09
COMMON SHARES
Basic Shares Outstanding	9.428M	9.428M
Diluted Shares Outstanding	9.724M	9.707M

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.835M	$6.094M
YoY Change	-11.3%	0.36%
Cash & Equivalents	$4.835M	$6.094M
Short-Term Investments
Other Short-Term Assets	$2.529M	$3.024M
YoY Change	37.99%	34.91%
Inventory	$12.54M	$12.59M
Prepaid Expenses	$2.529M	$3.024M
Receivables	$15.69M	$15.02M
Other Receivables	$1.737M	$1.541M
Total Short-Term Assets	$37.33M	$38.27M
YoY Change	-7.08%	-4.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.96M	$14.26M
YoY Change	11.28%	17.39%
Goodwill	$4.782M	$4.782M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$23.46M	$24.60M
YoY Change	9.01%	20.99%
Other Assets	$504.9K	$521.3K
YoY Change
Total Long-Term Assets	$49.97M	$50.53M
YoY Change	7.39%	14.25%
TOTAL ASSETS
Total Short-Term Assets	$37.33M	$38.27M
Total Long-Term Assets	$49.97M	$50.53M
Total Assets	$87.31M	$88.80M
YoY Change	0.69%	5.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.488M	$6.354M
YoY Change	2.86%	5.32%
Accrued Expenses	$2.881M	$3.667M
YoY Change	3.98%	22.73%
Deferred Revenue
YoY Change
Short-Term Debt	$3.975M	$5.811M
YoY Change	-44.01%	6.62%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.36M	$15.85M
YoY Change	-17.43%	9.47%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$165.3K	$95.58K
YoY Change	-17.69%	-22.56%
Total Long-Term Liabilities	$2.001M	$1.932M
YoY Change	9.71%	9.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.36M	$15.85M
Total Long-Term Liabilities	$2.001M	$1.932M
Total Liabilities	$15.36M	$17.79M
YoY Change	-14.68%	9.45%
SHAREHOLDERS EQUITY
Retained Earnings	$52.28M	$51.24M
YoY Change	2.93%	1.34%
Common Stock	$22.91M	$22.57M
YoY Change	7.83%	7.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$68.35M	$67.29M
YoY Change
Total Liabilities & Shareholders Equity	$87.31M	$88.80M
YoY Change	0.69%	5.56%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	$1.701M	$895.5K
YoY Change	92.17%	78.3%
Depreciation, Depletion And Amortization	$290.4K	$307.0K
YoY Change	28.51%	16.79%
Cash From Operating Activities	$2.566M	$3.077M
YoY Change	1168.54%	53.65%
INVESTING ACTIVITIES
Capital Expenditures	$1.082M	$390.7K
YoY Change	-27.3%	-4.49%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$1.082M	-$423.9K
YoY Change	-26.38%	-6.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.742M	-$2.020M
YoY Change	-543.19%	176.54%
NET CHANGE
Cash From Operating Activities	2.566M	$3.077M
Cash From Investing Activities	-1.082M	-$423.9K
Cash From Financing Activities	-2.742M	-$2.020M
Net Change In Cash	-1.258M	$687.9K
YoY Change	93.96%	-6.09%
FREE CASH FLOW
Cash From Operating Activities	$2.566M	$3.077M
Capital Expenditures	$1.082M	$390.7K
Free Cash Flow	$1.484M	$2.686M
YoY Change	-215.39%	68.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	34202	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	13096489	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2019029	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6094032	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5406173	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	usd
CY2023Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1102241	usd
CY2022Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1189404	usd
CY2022Q4	ntic	Fees For Services Provided To Joint Ventures FeesForServicesProvidedToJointVentures	1181805	usd
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12847401	usd
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-31
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0000875582
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2022Q4	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0
CY2023Q4	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	533000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	533000	usd
CY2023Q4	ntic	Trade Receivables Excluding Joint Ventures Net Current TradeReceivablesExcludingJointVenturesNetCurrent	14239360	usd
CY2023Q3	ntic	Trade Receivables Excluding Joint Ventures Net Current TradeReceivablesExcludingJointVenturesNetCurrent	15645130	usd
CY2023Q4	ntic	Trade Receivables Joint Ventures Current TradeReceivablesJointVenturesCurrent	778625	usd
CY2023Q3	ntic	Trade Receivables Joint Ventures Current TradeReceivablesJointVenturesCurrent	187912	usd
CY2023Q4	ntic	Fees Receivable For Services Provided To Joint Ventures Current FeesReceivableForServicesProvidedToJointVenturesCurrent	1220680	usd
CY2023Q3	ntic	Fees Receivable For Services Provided To Joint Ventures Current FeesReceivableForServicesProvidedToJointVenturesCurrent	1296594	usd
CY2023Q4	ntic	Dividend Receivable From Joint Venture DividendReceivableFromJointVenture	320068	usd
CY2023Q3	ntic	Dividend Receivable From Joint Venture DividendReceivableFromJointVenture	1986027	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	12592515	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3024134	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	38269414	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	39671556	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14256990	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14065354	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	24599520	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	23705714	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	521329	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	530944	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4782376	usd
CY2023Q3	us-gaap	Goodwill Goodwill	4782376	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	7334274	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	6353124	usd
CY2023Q4	ntic	Fees For Services Provided To Joint Ventures FeesForServicesProvidedToJointVentures	1248958	usd
CY2023Q4	ntic	Income From Joint Venture Operations IncomeFromJointVentureOperations	2351199	usd
CY2022Q4	ntic	Income From Joint Venture Operations IncomeFromJointVentureOperations	2371209	usd
CY2023Q4	us-gaap	Selling Expense SellingExpense	3686058	usd
CY2022Q4	us-gaap	Selling Expense SellingExpense	3507434	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3517061	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3130599	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1105921	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1256724	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	8309040	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	7894757	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	1376433	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	829576	usd
CY2023Q4	us-gaap	Investment Income Net InvestmentIncomeNet	46442	usd
CY2022Q4	us-gaap	Investment Income Net InvestmentIncomeNet	6168	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	111138	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	91331	usd
CY2023Q4	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	1311737	usd
CY2022Q4	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	744413	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	226796	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	110733	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	1084941	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	633680	usd
CY2023Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	189420	usd
CY2022Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	131438	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	895521	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	502242	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9427588
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9317680
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9706581
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9718931
CY2023Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2022Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2023Q4	us-gaap	Profit Loss ProfitLoss	1084941	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	633680	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	301319	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-53917	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1386260	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	579763	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	183797	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-138225	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1202463	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	717988	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	67244296	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	416563	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	38696	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	329522	usd
CY2022Q4	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	80000	usd
CY2022Q4	us-gaap	Dividends Dividends	655645	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	633680	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-53917	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	70698797	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	40096	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	350933	usd
CY2023Q4	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	800000	usd
CY2023Q4	us-gaap	Dividends Dividends	659932	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	1084941	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	301319	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	71016154	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	1084941	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	633680	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	350933	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	329522	usd
CY2023Q4	us-gaap	Depreciation Depreciation	307010	usd
CY2022Q4	us-gaap	Depreciation Depreciation	262876	usd
CY2023Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	147655	usd
CY2022Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	147811	usd
CY2023Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1102241	usd
CY2022Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1189404	usd
CY2023Q4	us-gaap	Proceeds From Dividends Received ProceedsFromDividendsReceived	371103	usd
CY2022Q4	us-gaap	Proceeds From Dividends Received ProceedsFromDividendsReceived	3042688	usd
CY2023Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-15335	usd
CY2022Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	54376	usd
CY2023Q4	ntic	Increase Decrease In Trade Receivables Excluding Joint Ventures IncreaseDecreaseInTradeReceivablesExcludingJointVentures	-1385108	usd
CY2022Q4	ntic	Increase Decrease In Trade Receivables Excluding Joint Ventures IncreaseDecreaseInTradeReceivablesExcludingJointVentures	539925	usd
CY2023Q4	ntic	Increase Decrease In Trade Receivables Joint Ventures IncreaseDecreaseInTradeReceivablesJointVentures	590713	usd
CY2022Q4	ntic	Increase Decrease In Trade Receivables Joint Ventures IncreaseDecreaseInTradeReceivablesJointVentures	-104260	usd
CY2023Q4	ntic	Increase Decrease In Fees Receivable For Services Provided To Joint Ventures IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures	-75914	usd
CY2022Q4	ntic	Increase Decrease In Fees Receivable For Services Provided To Joint Ventures IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures	-641639	usd
CY2023Q4	ntic	Increase Decrease In Dividends Receivable From Joint Venture IncreaseDecreaseInDividendsReceivableFromJointVenture	-1986027	usd
CY2022Q4	ntic	Increase Decrease In Dividends Receivable From Joint Venture IncreaseDecreaseInDividendsReceivableFromJointVenture	-0	usd
CY2023Q4	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	285866	usd
CY2022Q4	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	226731	usd
CY2023Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-525559	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-948661	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	929250	usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	252301	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	270194	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1573008	usd
CY2023Q4	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	9594	usd
CY2022Q4	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-18407	usd
CY2023Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-544411	usd
CY2022Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-254442	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3076892	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2002543	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	390729	usd
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	409094	usd
CY2023Q4	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	33142	usd
CY2022Q4	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	44445	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-423871	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-453539	usd
CY2023Q4	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-600000	usd
CY2022Q4	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-450000	usd
CY2023Q4	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	659932	usd
CY2022Q4	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	655645	usd
CY2023Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	416563	usd
CY2023Q4	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	800000	usd
CY2022Q4	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	80000	usd
CY2023Q4	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	40096	usd
CY2022Q4	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	38696	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2019836	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-730386	usd
CY2023Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	54673	usd
CY2022Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-86187	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	687858	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	732431	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5406174	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5333890	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6094032	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6066321	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4580739	usd
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4960355	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8011776	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8136134	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	12592515	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	13096489	usd
CY2023Q4	us-gaap	Land Land	496965	usd
CY2023Q3	us-gaap	Land Land	496965	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	17649550	usd
CY2023Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	17250392	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	6050458	usd
CY2023Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5984364	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24196973	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23731721	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9939983	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9666367	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14256990	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14065354	usd
CY2023Q4	us-gaap	Depreciation Depreciation	307010	usd
CY2022Q4	us-gaap	Depreciation Depreciation	262876	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9719859	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3674887	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6044972	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9686717	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3527232	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6159485	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	147655	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	147811	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	528439	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	543721	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	517990	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	492221	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	479012	usd
CY2023Q4	ntic	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	3483589	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6044972	usd
CY2023Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2023Q4	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2023-11-15
CY2022Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2022Q4	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2022-11-16
CY2023Q3	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	3496
CY2022Q3	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	3620
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	895521	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	502242	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9427588
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9317680
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	278993
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	401251
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9706581
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9718931
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1557131
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.08
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	269845
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	13.25
CY2023Q4	ntic	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Including Cashless Exercises ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodIncludingCashlessExercises	-0
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	-0
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1826976
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.4
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.05
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.85
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M18D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M28D
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	350933	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	329522	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2037871	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y9M
CY2023Q4	us-gaap	Revenues Revenues	20181675	usd
CY2022Q4	us-gaap	Revenues Revenues	19952766	usd
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12847401	usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13599642	usd
CY2023Q4	us-gaap	Revenues Revenues	20181675	usd
CY2022Q4	us-gaap	Revenues Revenues	19952766	usd
CY2023Q4	ntic	Total Fees For Services Provided To Joint Ventures Geographic Location TotalFeesForServicesProvidedToJointVenturesGeographicLocation	1248958	usd
CY2023Q4	ntic	Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage	1	pure
CY2022Q4	ntic	Total Fees For Services Provided To Joint Ventures Geographic Location TotalFeesForServicesProvidedToJointVenturesGeographicLocation	1181805	usd
CY2022Q4	ntic	Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage	1	pure
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14256990	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14065354	usd
CY2023Q4	us-gaap	Revenues Revenues	20181675	usd
CY2022Q4	us-gaap	Revenues Revenues	19952766	usd
CY2023Q4	ntic	Entity Wide Trade Joint Venture Receivables Three Joint Ventures Percentage EntityWideTradeJointVentureReceivablesThreeJointVenturesPercentage	0.682	pure
CY2023Q3	ntic	Entity Wide Trade Joint Venture Receivables Two Joint Ventures Percentage EntityWideTradeJointVentureReceivablesTwoJointVenturesPercentage	0.401	pure
CY2023Q4	us-gaap	Interest Paid Net InterestPaidNet	111138	usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet	91331	usd
CY2023Q4	ntic	Foreign Withholding Tax ForeignWithholdingTax	226796	usd
CY2022Q4	ntic	Foreign Withholding Tax ForeignWithholdingTax	110733	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
ntic-20231130_lab.xml	Edgar Link	unprocessable
ntic-20231130_cal.xml	Edgar Link	unprocessable
ntic-20231130_pre.xml	Edgar Link	unprocessable
0001171843-24-000207-index-headers.html	Edgar Link	pending
0001171843-24-000207-index.html	Edgar Link	pending
0001171843-24-000207.txt	Edgar Link	pending
R42.htm	Edgar Link	pending
0001171843-24-000207-xbrl.zip	Edgar Link	pending
ex_612068.htm	Edgar Link	pending
ex_612069.htm	Edgar Link	pending
ex_612070.htm	Edgar Link	pending
ex_612071.htm	Edgar Link	pending
ex_612072.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ntic-20231130.xsd	Edgar Link	pending
ntic20231130_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
ntic20231130_10q_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ntic-20231130_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NTIC
NORTHERN TECHNOLOGIES INTERNATIONAL CORP Stock $ntic

2024 Q1 Form 10-Q Financial Statement

#000117184324000207 Filed on January 11, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTIC NORTHERN TECHNOLOGIES INTERNATIONAL CORP Stock $ntic

2024 Q1 Form 10-Q Financial Statement

#000117184324000207 Filed on January 11, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTIC
NORTHERN TECHNOLOGIES INTERNATIONAL CORP Stock $ntic